Nat Rev Drug Discov 6:904916 (Erratum in: Nat Rev Drug Discov 7:185) Antons KA, Williams CD, Baker SK, Phillips PS (2006) Clinical perspectives of statin-induced rhabdomyolysis
It is studied in laboratory and preclinical models for its ability to activate target receptor pathways, contributing to the characterization of endocrine and neuroendocrine signaling
Preclinical studies show BPC 157 upregulates growth hormone receptors in tendon fibroblasts, offering a mechanistic basis for improved tendon-to-bone healing (Chang et al., J Appl Physiol, 2011)
For many, a daily pill fits naturally into a morning routine and improves consistency
-, , , / , [1]
Insulin-like growth factor-1 and cognitive health: Exploring cellular, preclinical, and clinical dimensions